1. Home
  2. NU vs BSX Comparison

NU vs BSX Comparison

Compare NU & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nu Holdings Ltd.

NU

Nu Holdings Ltd.

HOLD

Current Price

$11.89

Market Cap

61.8B

Sector

Finance

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$42.14

Market Cap

68.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NU
BSX
Founded
2013
1979
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.8B
68.0B
IPO Year
2016
2010

Fundamental Metrics

Financial Performance
Metric
NU
BSX
Price
$11.89
$42.14
Analyst Decision
Buy
Buy
Analyst Count
23
31
Target Price
$18.97
★ $54.68
AVG Volume (30 Days)
★ 82.5M
15.1M
Earning Date
11-12-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 55.20
EPS
N/A
★ 1.51
Revenue
N/A
★ $9,076,000,000.00
Revenue This Year
$226.17
$4.43
Revenue Next Year
$23.95
$3.95
P/E Ratio
$33.29
★ $28.10
Revenue Growth
N/A
★ 12.49
52 Week Low
$11.20
$39.57
52 Week High
$18.98
$105.65

Technical Indicators

Market Signals
Indicator
NU
BSX
Relative Strength Index (RSI) 31.95 40.29
Support Level $11.79 N/A
Resistance Level $14.60 $46.06
Average True Range (ATR) 0.56 1.39
MACD -0.38 -0.09
Stochastic Oscillator 6.67 39.53

Price Performance

Historical Comparison
NU
BSX

About NU Nu Holdings Ltd.

Nu Holdings Ltd is a Brazilian financial technology firm that offers digital banking services. Its services include Retail credit, SME credit, Payments, Customer assets, Insurance brokerage, E-commerce marketplace, and Mobile virtual network operator. It operates in single operating segment and geographically it operates in Brazil, Mexico, and Other countries with the majority of revenue deriving from Brazil.

About BSX Boston Scientific Corporation

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: